Cedric Francois - Mar 21, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
Mar 21, 2023
Transactions value $
-$1,272,821
Form type
4
Date filed
3/23/2023, 04:55 PM
Previous filing
Mar 1, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $80.1K +30K +2.62% $2.67* 1.17M Mar 21, 2023 Direct F1
transaction APLS Common Stock Sale -$1.88M -30K -2.55% $62.74 1.14M Mar 21, 2023 Direct F1, F2
transaction APLS Common Stock Options Exercise $53.4K +20K +1.75% $2.67* 1.16M Mar 22, 2023 Direct F3
transaction APLS Common Stock Options Exercise $376K +100K +8.59% $3.76* 1.26M Mar 22, 2023 Direct
transaction APLS Common Stock Options Exercise $100K +7.22K +0.57% $13.85 1.27M Mar 22, 2023 Direct
holding APLS Common Stock 300K Mar 21, 2023 Indirect Owner (The Francois Grossi Trust) F4
holding APLS Common Stock 234K Mar 21, 2023 Indirect Owner (The Francois-DuBois Educational Trust) F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -30K -6.67% $0.00 420K Mar 21, 2023 Common Stock 30K $2.67 Direct F3, F6
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -20K -4.76% $0.00 400K Mar 22, 2023 Common Stock 20K $2.67 Direct F3, F6
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -100K -62.96% $0.00 58.8K Mar 22, 2023 Common Stock 100K $3.76 Direct F7
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -7.22K -2.57% $0.00 274K Mar 22, 2023 Common Stock 7.22K $13.85 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise & sale from 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $62.02 to $63.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This is a scheduled exercise from 10B5-1 trading plan.
F4 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F5 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F6 This option was granted on December 5, 2013 and fully vested.
F7 This option was granted on February 8, 2016 and fully vested.
F8 This option was granted on February 8, 2019 and fully vested.